Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size by Modality

  2.3.2 Market Size by Application

  2.3.3 Market Size by End User

 2.4 Market Share & Bps Analysis by Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors

  3.4.4 End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Preclinical Imaging Modality Metrics

4.1.1 Share (%) of preclinical imaging demand by optical imaging, micro-MRI, micro-CT, PET, SPECT, ultrasound, and multimodal imaging systems globally.

4.1.2 Growth (%) in preclinical imaging system installations during 2025 and 2026.

4.1.3 Increase (%) in adoption of multimodal imaging platforms across research institutions and pharmaceutical companies globally.

4.2 Drug Discovery & Research Application Metrics

4.2.1 Share (%) of preclinical imaging utilization across oncology, neurology, cardiology, infectious diseases, immunology, and regenerative medicine research globally.

4.2.2 Growth (%) in imaging-based drug discovery and translational research activities worldwide.

4.2.3 Increase (%) in biomarker-driven preclinical studies utilizing advanced imaging technologies globally.

4.3 Pharmaceutical & Biotechnology R&D Metrics

4.3.1 Share (%) of preclinical imaging demand generated from pharmaceutical companies, biotechnology firms, CROs, academic institutes, and government research organizations globally.

4.3.2 Growth (%) in preclinical R&D expenditure supporting imaging technology adoption worldwide.

4.3.3 Increase (%) in outsourcing of imaging studies to contract research organizations globally.

4.4 AI, Automation & Imaging Innovation Metrics

4.4.1 Share (%) of preclinical imaging workflows utilizing AI-powered image analysis, automated quantification, and advanced visualization tools globally.

4.4.2 Growth (%) in adoption of cloud-based imaging analytics and digital research platforms worldwide.

4.4.3 Increase (%) in investments toward next-generation molecular imaging, magnetic particle imaging (MPI), and high-resolution imaging technologies globally.

4.5 Regional Research Infrastructure Metrics

4.5.1 Share (%) of global preclinical imaging demand across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

4.5.2 Growth (%) in life sciences research funding and biomedical infrastructure investments across major economies.

4.5.3 Increase (%) in preclinical research activities supporting drug development and precision medicine initiatives globally.

5. Preclinical Imaging Market Segmental Analysis & Forecast, By Modality, 2022–2035, Value (USD Billion)

5.1 Introduction

5.2 Optical Imaging/Bioluminescence & Fluorescence Imaging

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

5.3 PET/Positron Emission Tomography

5.4 SPECT

5.5 MRI

5.6 CT

5.7 Ultrasound

5.8 Photoacoustic Imaging

5.9 Multimodal/Hybrid Imaging Systems

6. Preclinical Imaging Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Research & Development

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2035

   6.3 Drug Discovery & Development

   6.4 Toxicology Studies

   6.5 Disease Mechanism Studies

   6.6 Oncology Research

   6.7 Neurology Research

   6.8 Others

7. Preclinical Imaging Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

7.1 Introduction

7.2 Pharmaceutical & Biotechnology Companies

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2035

7.3 Research Institutes & Academic Centres

7.4 Contract Research Organizations

7.5 Others

8. Preclinical Imaging Market Segmental Analysis & Forecast, By Region, 2022 – 2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 Preclinical Imaging Market Size & Forecast, By Modality, 2022–2035

 8.2.3 Preclinical Imaging Market Size & Forecast, By Application, 2022–2035

 8.2.4 Preclinical Imaging Market Size & Forecast, By End User, 2022–2035

 8.2.5 Preclinical Imaging Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 Preclinical Imaging Market Size & Forecast, By Modality, 2022–2035

 8.3.3 Preclinical Imaging Market Size & Forecast, By Application, 2022–2035

 8.3.4 Preclinical Imaging Market Size & Forecast, By End User, 2022–2035

 8.3.5 Preclinical Imaging Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Russia

  8.3.5.7 Poland

  8.3.5.8 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 Preclinical Imaging Market Size & Forecast, By Modality, 2022–2035

 8.4.3 Preclinical Imaging Market Size & Forecast, By Application, 2022–2035

 8.4.4 Preclinical Imaging Market Size & Forecast, By End User, 2022–2035

 8.4.5 Preclinical Imaging Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 Preclinical Imaging Market Size & Forecast, By Modality, 2022–2035

 8.5.3 Preclinical Imaging Market Size & Forecast, By Application, 2022–2035

 8.5.4 Preclinical Imaging Market Size & Forecast, By End User, 2022–2035

 8.5.5 Preclinical Imaging Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Argentina

  8.5.5.3 Mexico

  8.5.5.4 Colombia

  8.5.5.5 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 Preclinical Imaging Market Size & Forecast, By Modality 2022–2035

 8.6.3 Preclinical Imaging Market Size & Forecast, By Application, 2022–2035

 8.6.4 Preclinical Imaging Market Size & Forecast, By End User, 2022–2035

 8.6.5 Preclinical Imaging Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 Qatar

  8.6.5.4 South Africa

  8.6.5.5 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2022 – 2035

  9.2.3 Number of Strategies Adopted by Key Players, 2025

 9.3 Market Share Analysis, 2025

 9.4 Product/Service & Application Benchmarking

  9.4.1 Product/Service Specifications & Features by Key Players

  9.4.2 Product/Service Heatmap by Key Players

  9.4.3 Application Heatmap by Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

9.6.1 PerkinElmer Inc. (Revvity)

  9.6.1.1 Company Overview & Snapshot

  9.6.1.2 Product/Service Portfolio

  9.6.1.3 Key Company Financials

  9.6.1.4 SWOT Analysis

9.6.2 Bruker Corporation

9.6.3 Siemens Healthineers AG

9.6.4 GE HealthCare Technologies Inc.

9.6.5 FUJIFILM VisualSonics Inc.

9.6.6 MR Solutions Ltd.

9.6.7 Miltenyi Biotec B.V. & Co. KG

9.6.8 Mediso Ltd.

9.6.9 Aspect Imaging Ltd.

9.6.10 TriFoil Imaging Inc.

9.6.11 Scanco Medical AG

9.6.12 BioSpace Lab S.A.S.

9.6.13 LI-COR Biosciences, Inc.

9.6.14 Photon etc. Inc.

9.6.15 Rigaku Corporation

9.6.16 Canon Medical Systems Corporation

9.6.17 Agilent Technologies, Inc.

9.6.18 Thermo Fisher Scientific Inc.

9.6.19 Shimadzu Corporation

9.6.20 SMI (Sofie Molecular Imaging) Inc.

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions on Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List of Tables

 13.2 List of Figures